MedPath
FDA Approval

MORPHINE SULFATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 7, 2011
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Morphine(10 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MORPHINE SULFATE

Product Details

NDC Product Code
54868-5413
Application Number
NDA022195
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
April 6, 2011
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 10 mg in 5 mL
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
FD&C GREEN NO. 3Inactive
Code: 3P3ONR6O1SClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath